Almac Group Appoints New Site Head for Charnwood Campus, Loughborough, UK
Craigavon, N.I., UK, 27 Aug 2018 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, has announced the appointment of a new Site Head for its Charnwood campus, in Loughborough, UK.
James Hurst, who joined Almac Pharma Services in 2008 as Analytical Manager, and in most recent years was Head of Pharmaceutical Development Operations at Almac’s global HQ site in Craigavon, has this year taken up the role of Site Head at the company’s new manufacturing and analytical facilities at the Charnwood Campus in Loughborough, UK.
Together with the Pharma Services’ Senior Management team, James will set the strategic direction of the site and will have responsibility for its operational management and performance.
James is a graduate of the Manchester Metropolitan University and holds a Bsc (Hons) in Chemistry.
John McQuaid, Vice-President Technical Operations of Almac Pharma Services commented “We are delighted that James has taken the position of Site Head at our Charnwood campus. James was key to the successful growth of our pharmaceutical development service offering at Craigavon and we look forward to him using this experience to drive the growth of operations at Charnwood as we increase capacity to support our global client base.”
About Almac Group
‘Partnering to Advance Human Health’
The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown over almost 50 years and now employs close to 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in Europe, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).